Tetrazole Research Selection Guide: From Basic Concepts to Structural Features, Classification & Application Scenarios, Selection Considerations, and Product Navigation (Tables 1–4)
Tetrazole Research Selection Guide: From Basic Concepts to Structural Features, Classification & Application Scenarios, Selection Considerations, and Product Navigation (Tables 1–4)
From Structure to Application: Why Tetrazoles Matter in Pharmaceuticals, Materials, and Research
In this article, “tetrazole” refers to the five-membered nitrogen heterocycle composed of one carbon and four nitrogens. For readability, we use tetrazole throughout. The importance of tetrazoles is not simply “having many nitrogens,” but rather that this small ring simultaneously offers planarity, aromaticity, ionizability, strong hydrogen-bond participation, and multi-nitrogen coordination potential—making it highly representative in medicinal chemistry, coordination chemistry, materials research, cell-based assays, and nucleic-acid chemistry.

I. Why Tetrazoles Deserve to Be Recognized as a Distinct Family
Tetrazoles were not among the earliest heterocycles to attract broad attention, but research accelerated markedly from the mid-to-late 20th century onward across pharmaceuticals, agriculture, biochemistry, and energetic materials. A key reason is that the tetrazole ring can both (1) deliver the electronic/coordination characteristics of a “high-nitrogen heterocycle,” and (2) serve as a functional design element that can replace certain common functional groups, especially carboxylic-acid fragments.
In medicinal chemistry, one of the most classic roles of tetrazoles is as a bioisostere of carboxylic acids; in materials and coordination chemistry, tetrazoles leverage multiple nitrogen sites to build coordination networks and functional materials.
II. Basic Concept: What Is a Tetrazole?
At the most basic level, tetrazole is a high-nitrogen five-membered heteroaromatic ring. The parent tetrazole consists of a ring framework made of one carbon and four nitrogens; “tetrazole derivatives” refer to a broad class of compounds obtained by introducing substituents at different ring positions. In practice, research most often involves not the “bare” parent tetrazole, but rather 5-substituted tetrazoles, 1,5-disubstituted tetrazoles, aminotetrazoles, thio-/mercapto-tetrazoles, tetrazolium salts, and fused/bridged tetrazole systems, among others.
Because different tetrazole types can differ substantially in acidity, coordination ability, reactivity, ADME-relevant properties, and materials performance, “tetrazole” is better understood as a functional scaffold family rather than a single molecule.
III. Structural Features of Tetrazoles
This can be understood in four steps.
1) A high-nitrogen, planar five-membered ring
The tetrazole ring is a planar, conjugated nitrogen heteroaromatic. Its high nitrogen content gives it distinctive electronic features and also underpins its potential in coordination, molecular recognition, and energetic-material directions. The literature repeatedly emphasizes that the planar framework and multi-nitrogen conjugated system are fundamental to why tetrazoles can serve both medicinal chemistry and materials chemistry.
2) Tautomerism matters—tetrazoles are not a “single fixed drawing”
Tetrazoles can involve 1H and 2H tautomeric forms. A 5H form is also discussed in the literature, but the most common, stable, and practically meaningful forms are those related to 1H/2H systems. In general, 5H is often regarded as a relatively higher-energy tautomer, more likely to be considered under specific substitution patterns, strong fields/solvents, or special research conditions. In most routine contexts of organic synthesis and medicinal chemistry, 1H/2H tautomerism is the dominant factor governing spectral interpretation, site assignment, and binding/coordination patterns.
For substituted tetrazoles, tautomerism can affect NMR interpretation, positional assignment of substitution, regioselectivity, and binding modes to targets/metals. Thus, tetrazoles require explicit consideration of conformation and electron distribution rather than “draw the ring and move on.”
3) Meaningful acidity—often able to mimic carboxylic acids
In medicinal chemistry, “tetrazole replacing a carboxylic acid” typically refers specifically to 5-substituted 1H-tetrazoles (tetrazolic acids that retain an N–H). Because they preserve an ionizable N–H, they can be closer to carboxylic acids in acid recognition and ionic interactions. By contrast, N-substituted / 1,5-disubstituted tetrazoles often show different ionization and interaction logic; they are more often discussed as structural/conformational isosteres or linker elements rather than simple “carboxylate mimics.”
Tetrazolic acids (especially 5-substituted 1H-tetrazoles) are commonly reported to have acidity close to carboxylic acids, with a typical pKa range of ~4.5–4.9. This value can shift considerably depending on the electronic effects of the 5-substituent, solvent, and ionic strength; practical work should rely on the specific fragment and measurement conditions. This means that near physiological pH, many tetrazole groups exist in a deprotonated form, enabling ionic interactions and hydrogen-bond networks—one reason tetrazoles are frequently used to replace carboxylic acids.
4) Not “identical to carboxylic acids”—“carboxylic-like,” but not the same
Tetrazoles are often chosen as carboxylic-acid replacements not only because acidity can be similar, but also because they are planar, delocalized acidic fragments. However, tetrazoles are slightly larger, their negative charge is typically more delocalized, their hydrogen-bonding environment can extend farther outward, and they are often more lipophilic than the corresponding carboxylates. This is part of their value: rather than simply copying carboxylic acids, tetrazoles can preserve acidic recognition while providing a different spatial/electronic distribution.
IV. Classification of Tetrazoles
Classification dimension | Representative types | Structural / property highlights | Common research significance |
By core state | 1H-/2H-tetrazoles | Tautomerism exists; electron distribution and spectral interpretation require attention | Fundamental structure studies, mechanisms, regioselectivity analysis |
By substitution pattern | 5-substituted tetrazoles | The most common and most practical class | Often used as carboxylic-acid replacements in medicinal chemistry |
By substitution pattern | 1,5-disubstituted tetrazoles | Further tunes lipophilicity, conformation, and binding modes | Lead optimization, functional-molecule design |
By functionalization direction | Aminotetrazoles, hydroxy-/thio-tetrazoles, etc. | Can markedly change acidity, coordination, and reactivity | Coordination chemistry, energetic materials, intermediate chemistry |
By ionic form | Tetrazolium salts | Positively charged; can be reduced to colored formazans | Cell viability or enzyme-activity assays (e.g., MTT/XTT) |
By scaffold complexity | Fused/bridged/multi-tetrazole systems | Multi-site, multi-coordination, multi-responsive | Functional materials, MOFs/coordination polymers, energetic systems |
Note: This table reflects a common research-facing logic for the tetrazole family: use tautomerism/substitution to view “structure,” functionalization/ionic forms to view “function,” and scaffold complexity to view “application scenarios.”
V. Where Tetrazoles Are Commonly Used—and What Unique Roles They Play
Application area | Core role played by tetrazoles | Representative note |
Medicinal chemistry | Bioisosteres of carboxylic acids: preserve acidic recognition while altering lipophilicity and charge distribution | Classic in AT1 receptor antagonists such as losartan, valsartan, candesartan, etc. |
Antibacterial/anticancer/metabolic-disease lead design | Provide a stable N-heteroaromatic scaffold participating in H-bond, ionic, and hydrophobic recognition | Tetrazole scaffolds appear across many bioactive-molecule research efforts |
Cell and enzyme activity analysis | Tetrazolium salts can be reduced to colored formazans for colorimetric readout | MTT is a classic tetrazolium system |
Coordination chemistry / functional materials | Multiple N sites can serve as coordination or bridging sites | Enables coordination polymers; luminescent/ferroelectric/dielectric-related materials |
Nucleic-acid chemistry | Acidic activator in oligonucleotide phosphoramidite chemistry | 1H-tetrazole is a classic activator in phosphoramidite methods |
Energetic materials | High nitrogen content, high enthalpy of formation, diverse energetic derivatives | Tetrazole motifs are common high-nitrogen energetic building units |
Additional perspective: These applications may appear wide-ranging, but they share a consistent underlying logic: tetrazoles combine the electronic character of high-nitrogen heterocycles with engineerable functional behavior. They can behave like acidic recognition fragments in drugs, multi-dentate ligands in materials, or chromogenic ionic structures in analytical systems.
VI. What Tetrazoles Do Uniquely
1) In medicinal chemistry: often used to “replace carboxylic acids,” but not only that
A classic advantage of tetrazoles is that they can maintain acidic recognition without fully losing it, while giving a molecule different spatial, electronic, and lipophilicity characteristics than a carboxylic acid. This can make tetrazoles the better acidic fragment in certain projects. The development of AT1 receptor antagonists is a representative case, with the tetrazole-bearing losartan becoming a well-known successful structure.
2) In materials/coordination: both a “nitrogen-rich skeleton” and a “connection node”
With multiple potential coordinating nitrogens, tetrazoles are well suited as bridging or multi-site ligands to build coordination polymers and network structures. Reported tetrazole coordination polymers can exhibit second-harmonic generation, fluorescence, ferroelectricity, and dielectric properties—showing tetrazoles are not merely “organic-synthesis intermediates,” but structural tools in functional materials design.
3) In analytical assays: turning “biochemical processes” into readable color
Many researchers first encounter tetrazole-related systems not in medicinal chemistry, but in cell experiments. Tetrazolium salts such as MTT can be reduced in metabolically active cells to colored products used as readouts for viability, proliferation, or dehydrogenase-related activity. The key here is not neutral tetrazole, but the tetrazolium–formazan system—an important conceptual distinction.
4) In nucleic-acid chemistry: enabling “high-efficiency activation” with practical operability
According to IUPAC-related materials, tetrazole was selected as an acidic activator in classic oligonucleotide phosphoramidite methods partly because it can be purified by sublimation, stored as an anhydrous solid, and used under anhydrous acetonitrile conditions—better fitting routine DNA synthesis workflows. In practical terms, tetrazoles address a very real research need: making highly reactive activation steps more operable and more reproducible.
VII. When to Prioritize Tetrazoles
Research scenario | When to consider tetrazoles | Rationale |
Lead optimization in medicinal chemistry | When a molecule contains a carboxylic acid but you need to rebalance activity, binding mode, and physicochemical properties | Tetrazoles often provide similar acidic recognition while altering lipophilicity and charge distribution |
Target-binding design | When an acidic site needs to form relatively stable interactions with basic residues | Deprotonated tetrazoles can participate in ionic/H-bond networks |
Coordination-material design | When multi-nitrogen ligands, bridging nodes, or higher-dimensional networks are needed | Multiple N sites are suitable for bridging metal centers |
Cell assays / enzyme activity assays | When you want a visual/colorimetric metabolic readout | Tetrazolium salts can be converted to colored formazans |
DNA/RNA synthesis | When assembling oligonucleotides via phosphoramidite strategies | Tetrazole can serve as a classic activator |
Energetic-scaffold design | When the goal is a high-nitrogen, structurally tunable unit | Tetrazoles provide high nitrogen content and strong energetic-scaffold value |
VIII. Key Considerations When Choosing Tetrazoles
Consideration | Why it matters |
Do not treat tetrazoles as a “fully equivalent replacement” for carboxylic acids | Even with similar acidity, tetrazoles are larger, have more delocalized negative charge, and a more extended H-bonding environment; binding modes may change |
Pay attention to tautomerism and positional assignment | 1H/2H tautomerism affects spectra, naming, reactive sites, and binding interpretation |
Evaluate pKa, solubility, and membrane permeability | Tetrazoles are often negatively charged under physiological conditions, which may improve or worsen overall ADME balance |
Check metabolism and salt-formation behavior | Tetrazole rings may undergo metabolism such as N-glucuronidation (reported for ARBs like losartan/candesartan); evaluation should consider pathways and exposure, not only potency |
Clearly distinguish “neutral tetrazoles” from “tetrazolium salts” | The two differ completely in charge, use cases, and experimental logic |
Prioritize safety during synthesis | 5-Substituted 1H-tetrazoles are commonly made via [3+2] cycloaddition of nitriles with azide reagents; manage azide risks and possible exotherms/thermal decomposition/impact or friction sensitivity in some high-nitrogen systems; prefer temperature control, dropwise/portionwise addition, and thorough quenching |
Run a separate risk assessment for scale-up | Safety depends strongly on substituents, salt forms, energetic state, solvent system, and azide/hydrazoic acid (HN₃)-related side reactions; before scale-up, perform stepwise calorimetry, gas-evolution risk assessment, and process-boundary evaluation—do not extrapolate directly from small-scale experience |
IX. Tetrazole-Related Product Navigation: Quickly Locate Tables 1–4 by Research Task
Scenario tag | Research task / experimental need | Recommended table(s) to check first | Selection rationale |
Tetrazole scaffold synthesis | Starting from the tetrazole core to modify structures; synthesizing 5-substituted tetrazoles, N-substituted tetrazoles, or tetrazole derivatives bearing carboxyl/amino/thiol groups | Table 1: Core tetrazole building blocks, functionalized intermediates, and dual-N ligands | Table 1 focuses on parent tetrazoles and common functionalized intermediates (methyl, amino, carboxylic acid/ester, acetic acid, phenyl, mercapto, pyridyl tetrazoles), supporting synthetic routes that “expand outward from the core scaffold.” |
Carboxylic-acid bioisostere design | Replacing a carboxylic acid in a drug/lead with a tetrazole to optimize acidity, metabolic stability, or receptor-binding features | Table 1 | Table 1 includes classic fragments such as 5-phenyl tetrazole, tetrazole carboxylic acid, and tetrazole acetic acid—closest to medicinal-chemistry needs for introducing tetrazoles as carboxylate replacements. |
Coordination chemistry / MOFs / functional materials | Selecting nitrogen-rich ligands with multiple coordination sites for metal complexes, coordination polymers, MOFs, luminescent or magnetic materials | Table 1 | Pyridyl tetrazoles, aminotetrazoles, and mercapto tetrazoles in Table 1 provide tetrazole N plus additional pyridine N / amino / sulfur donor sites—better aligned with coordination/material selections. |
High-nitrogen compounds / energetic materials | High-nitrogen scaffolds for energetic materials, gas generators, or high-nitrogen functional molecules | Table 1 | 5-Aminotetrazole and its monohydrate in Table 1 are representative starting materials for high-nitrogen tetrazole research. |
DNA/RNA solid-phase synthesis | Phosphoramidite coupling in oligonucleotide synthesis; selecting tetrazole-type activators to improve coupling efficiency | Table 2: Oligonucleotide-synthesis activators and NMTT-related thio-tetrazoles | Table 2 collects commonly used activators (tetrazole, ETT, BTT, Activator 42, etc.), directly matching key steps in manual/automated oligonucleotide synthesis. |
Difficult monomer coupling optimization | Sterically hindered monomers, RNA monomers, or unstable coupling efficiency; screening stronger/more suitable activators | Table 2 | In addition to classic tetrazole, Table 2 includes more “efficiency-optimization” activators such as ETT, BTT, and Activator 42 for condition comparison and process optimization. |
Cephalosporin NMTT side-chain mechanism studies | Studying NMTT side-chain release, disulfiram-like reactions, ALDH inhibition, or coagulation-related risk mechanisms | Table 2 + Table 4 | Table 2 provides the NMTT reference compound for mechanistic validation; Table 4 lists NMTT-containing cephalosporin/oxacephem drugs for drug-level comparative studies—these tables are often used together. |
Cell viability / cytotoxicity assays | MTT, MTS, XTT, WST-1, WST-8 colorimetric assays for proliferation, viability, or drug toxicity | Table 3: Tetrazolium chromogenic reagents for cell viability & respiratory activity | Table 3 is dedicated to tetrazolium chromogenic systems and is the most direct reagent source for viability assays: MTT for classic workflows; WST/XTT/MTS for water-soluble, more convenient readouts. |
High-throughput screening / 96-well rapid assays | Reducing crystal-dissolution steps; improving throughput and operational convenience | Table 3 | MTS, XTT, WST-1, and WST-8 in Table 3 are water-soluble tetrazolium systems better suited to plate-based HTS than MTT alone. |
Microbial activity / respiratory metabolism assays | Assessing microbial respiration, colony activity, dehydrogenase activity, or active cells in environmental samples | Table 3 | CTC, TTC, INT, and NBT in Table 3 align more with microbial/environmental redox metabolism readouts and directly match respiration/dehydrogenase-related assays. |
ROS / redox chromogenic assays | Detecting superoxide, redox enzyme activity, or classic BCIP/NBT color development | Table 3 | NBT is a classic ROS/redox chromogenic substrate and is often more appropriate than general “cell viability reagents” for these experimental goals. |
ARB pharmacology / receptor studies | Studying AT1 receptor antagonists, angiotensin II pathways, or using biphenyl-tetrazole antihypertensives as reference compounds | Table 4: Tetrazole-containing drugs and NMTT-side-chain cephalosporin/oxacephem antibacterials | Table 4 concentrates on biphenyl-tetrazole ARBs (losartan, valsartan, irbesartan, olmesartan, candesartan, etc.), serving as direct pharmacology and reference sources. |
Prodrug vs active form comparison | Comparing prodrug vs active form (absorption, conversion, activity, formulation behavior) | Table 4 | Table 4 includes paired prodrug/active forms such as candesartan cilexetil/candesartan and olmesartan medoxomil/olmesartan for side-by-side comparison. |
Antibacterial susceptibility / β-lactam comparison | Selecting NMTT-side-chain cephalosporin/oxacephem antibiotics for susceptibility, mechanism, or safety comparison | Table 4 | Cefamandole, cefmetazole, cefoperazone, cefotetan, and latamoxef in Table 4 are representative for parallel evaluation of antibacterial activity and NMTT-related risks. |
Research on marketed tetrazole-containing drugs | APIs, reference standards, or analytical-method targets; understanding tetrazoles in real-world drugs | Table 4 | Table 4 covers ARBs, tedizolid phosphate, azosemide, and NMTT-side-chain antibacterials—best for understanding tetrazole value from “actual drug applications.” |
Table 1 | Core Tetrazole Building Blocks, Functionalized Intermediates, and Dual-N Ligands
Category | CAS No. | Aladdin Cat. No. | Name | Specification / Purity | Key features & applications |
Alkyl-substituted tetrazole building blocks | 4076-36-2 | 5-Methyltetrazole | ≥98% | A small alkyl-substituted tetrazole model substrate; commonly used to tune structure–acidity/lipophilicity, develop N-heterocycle methodology, and prepare downstream functionalized intermediates. | |
N-alkyl tetrazole building blocks | 16681-77-9 | 1-Methyl-1H-tetrazole | ≥98% (GC) | An N-methylated tetrazole model substrate; used to study N-substitution patterns of tetrazoles, med-chem fragment derivatization, and subsequent synthesis of sulfur-containing/functionalized tetrazoles. | |
Aminotetrazole high-nitrogen building blocks (energetics/coordination/materials) | 4418-61-5 | 5-Amino-1H-tetrazole | ≥98% | A representative high-nitrogen tetrazole; widely used in energetic materials, gas-generating agents, coordination chemistry, and high-nitrogen functional-molecule synthesis; also an important starting material for building multi-nitrogen scaffolds. | |
Aminotetrazole high-nitrogen building blocks (energetics/coordination/materials) | 15454-54-3 | 5-Amino-tetrazole-monohydrate | ≥99% | Monohydrate form of 5-aminotetrazole; likewise a common feedstock for high-nitrogen scaffolds and gas-generating agents, and suitable for coordination polymers and high-nitrogen functional materials research. | |
Tetrazole carboxylate ester building blocks (med-chem intermediates) | 55408-10-1 | Ethyl 1H-Tetrazole-5-carboxylate | ≥98% | A common tetrazole carboxylate ester intermediate; often easier to store than the corresponding acid and convenient for a two-step “ester hydrolysis → coupling” workflow, enabling rapid construction of 5-substituted tetrazole series. | |
Tetrazole carboxylic-acid building blocks (med-chem/coordination) | 75773-99-8 | 2H-1,2,3,4-tetrazole-5-carboxylic acid | ≥95% | A highly polar, nitrogen-rich carboxylic-acid building block; used to introduce tetrazoles as carboxylic-acid bioisosteres into candidates and as precursors for coordination chemistry/functional materials. | |
Tetrazole acetic-acid building blocks (med-chem/coordination) | 21743-75-9 | 1H-Tetrazole-5-acetic acid | ≥98% (T) | A dual-functional intermediate bearing both tetrazole and carboxymethyl; suitable for tetrazole modification of pharma/agrochem molecules, amide coupling, and coordination chemistry studies. | |
Aryl tetrazole bioisostere building blocks | 18039-42-4 | 5-Phenyl-1H-tetrazole | ≥99% | A classic representative 5-substituted tetrazole; commonly used as a carboxylic-acid bioisostere template in lead optimization, coupling/substitution methodology, and ligand design for coordination chemistry. | |
Mercapto/thio-tetrazole functional building blocks (coordination/corrosion inhibition/synthesis) | 86-93-1 | 5-Mercapto-1-phenyl-1H-tetrazole | ≥98% (HPLC) (T) | A mercapto aryl tetrazole combining a soft donor site with the tetrazole ring; commonly used as a corrosion inhibitor for copper/copper alloys, a metal-binding ligand, and a sulfur-containing tetrazole intermediate for surface protection, coordination chemistry, and downstream thioether derivatization. | |
Pyridyl-tetrazole dual-N ligands / med-chem building blocks | 33893-89-9 | 5-(2-Pyridyl)-1H-tetrazole | ≥98% | Contains both pyridine N and tetrazole N; the ortho arrangement favors chelation; used for metal complexes/MOF ligands, heteroaryl med-chem fragments, and catalytic-materials precursors. | |
Pyridyl-tetrazole dual-N ligands / med-chem building blocks | 3250-74-6 | 3-(2H-Tetrazol-5-yl)pyridine | ≥98% | Meta linkage favors bridging coordination; common in coordination polymers, MOFs, luminescent/magnetic materials precursors, and heteroaryl med-chem intermediates. | |
Pyridyl-tetrazole dual-N ligands / med-chem building blocks | 14389-12-9 | 5-(4-Pyridyl)-1H-tetrazole | ≥97% | Para-linked linear bridging is prominent; used to build 1D/2D coordination networks, MOFs and functional heteroaromatic materials, and as a heteroaryl fragment in medicinal chemistry. |
Table 2 | Oligonucleotide-Synthesis Activators and NMTT-Related Thio-Tetrazoles
Category | CAS No. | Aladdin Cat. No. | Name | Specification / Purity | Key features & applications |
Parent tetrazole / oligonucleotide-synthesis activator | 288-94-8 | T109596 | Tetrazole | ≥98% | Parent tetrazole; both a key starting point for 5-substituted tetrazole synthesis and a classic activator for phosphoramidite coupling in DNA/RNA solid-phase synthesis. |
Oligonucleotide-synthesis activator (phosphoramidite chemistry) | 89797-68-2 | 5-(Ethylthio)-1H-tetrazole (ETT) | ≥98% | A common nucleic-acid synthesis activator for phosphoramidite coupling; compared with classic tetrazole, it often provides stronger activation and better solubility in acetonitrile, helping improve coupling efficiency. | |
Oligonucleotide-synthesis activator (phosphoramidite chemistry) | 21871-47-6 | 5-(Benzylthio)-1H-tetrazole | ≥98.5% | A commonly used “BTT” activator; often advantageous for RNA monomers or sterically hindered phosphoramidite monomers, helping improve synthesis efficiency and purity. | |
Oligonucleotide-synthesis activator (high-efficiency aryl tetrazole) | 175205-09-1 | Activator 42 | 70–77 g/L (Activator 42 content, titration) | A high-acidity aryl-tetrazole activator; used for phosphoramidite coupling, particularly suitable for difficult monomers and optimization under automated DNA/RNA synthesis conditions. | |
NMTT side-chain reference compound (cephalosporin side chain / mechanism studies) | 13183-79-4 | 5-Mercapto-1-methyltetrazole (MMT) | ≥98% | A reference compound representing the NMTT moiety; commonly used to study ALDH inhibition, disulfiram-like reactions, and coagulation-risk mechanisms associated with NMTT-containing cephalosporins; also usable as a sulfur-containing tetrazole ligand or small molecule for surface modification. |
Table 3 | Tetrazolium Chromogenic Reagents for Cell Viability and Respiratory Activity
Category | CAS No. | Aladdin Cat. No. | Name | Specification / Purity | Key features & applications |
Tetrazolium respiratory-activity probe (microbiology/environment) | 90217-02-0 | 5-Cyano-2,3-di-(p-tolyl) tetrazolium chloride (CTC) | — | A classic redox probe for microbial respiratory activity; reduced by actively respiring cells to colored/fluorescent formazan, commonly used in flow cytometry, fluorescence microscopy, and identification of “active cells” in environmental samples. | |
Tetrazolium chromogenic reagent (microbiology/dehydrogenases) | 298-96-4 | 2,3,5-Triphenyl-tetrazolium chloride solution | Suitable for microbiology | A classic TTC staining system; reduced by live cells to red formazan, widely used for colony counting, food/water microbiological analysis, and dehydrogenase-activity assays. | |
Tetrazolium dehydrogenase / respiratory-activity chromogenic reagent | 146-68-9 | Iodonitrotetrazolium chloride (INT) | ≥98% | Commonly used as a chromogenic electron-transfer substrate for dehydrogenases/respiratory chains; used in microbial activity, soil dehydrogenase assays, and tissue/cell redox studies. | |
Tetrazolium redox / ROS chromogenic reagent | 298-83-9 | Nitro blue tetrazolium chloride (NBT) | Ultrapure grade | Widely used for superoxide/ROS color development and in BCIP/NBT staining systems; also used for visualization of dehydrogenase and redox activity—an established biochemical chromogenic substrate. | |
Tetrazolium cell-viability reagent | 298-93-1 | 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) | Ultrapure grade | A classic colorimetric substrate for cell viability/proliferation; broadly used in screening, cytotoxicity, and proliferation assays, but produces insoluble formazan and typically requires an additional dissolution step. | |
Water-soluble tetrazolium cell-viability reagent | 138169-43-4 | MTS Reagent | ≥95% (HPLC) | A water-soluble tetrazolium substrate; often used with electron-coupling reagents for rapid colorimetric detection of live-cell number, chemosensitivity, and cytotoxicity. | |
Water-soluble tetrazolium cell-viability reagent | 111072-31-2 | XTT sodium salt | ≥90% | A water-soluble tetrazolium for viability/proliferation assays; compared with MTT, avoids crystal dissolution steps and is also used for fungal and biofilm metabolic-activity evaluation. | |
Water-soluble tetrazolium cell-viability reagent | 150849-52-8 | WST-1 | ≥96% | A water-soluble viability substrate for 96-well-plate proliferation, cytotoxicity, and drug-sensitivity assays; readings correlate with metabolic activity of live cells. | |
Water-soluble tetrazolium cell-viability reagent | 193149-74-5 | WST-8 | ≥98% | A high-sensitivity water-soluble tetrazolium; commonly used in CCK-8 cell counting and proliferation/toxicity evaluation; produces a water-soluble product and requires no crystal dissolution, making it suitable for high-throughput detection. |
Table 4 | Tetrazole-Containing Drugs and NMTT-Side-Chain Cephalosporin/Oxacephem Antibacterials
Category | CAS No. | Aladdin Cat. No. | Name | Specification / Purity | Key features & applications |
Biphenyl-tetrazole ARB prodrug | 145040-37-5 | Candesartan Cilexetil | Moligand™, ≥98% | A typical biphenyl-tetrazole ARB prodrug; converted orally to candesartan; used in AT1 receptor antagonist studies, as API/reference material, and for prodrug-design comparisons. | |
Biphenyl-tetrazole ARB prodrug | 144689-63-4 | Olmesartan Medoxomil | Moligand™, ≥98% | Olmesartan prodrug retaining the key biphenyl-tetrazole pharmacophore; used in AT1 pharmacology, formulation studies, and prodrug-conversion research. | |
Biphenyl-tetrazole ARB active drug | 139481-59-7 | Candesartan | — | A typical active biphenyl-tetrazole ARB; used for AT1 receptor blockade studies, API/reference analyses, and mechanism verification. | |
Biphenyl-tetrazole ARB active drug | 144689-24-7 | Olmesartan | ≥98% | A typical active biphenyl-tetrazole ARB; the tetrazole ring is a key acidic binding fragment; used in receptor pharmacology, API analysis, and formulation research. | |
Biphenyl-tetrazole ARB active drug | 138402-11-6 | Irbesartan | Moligand™, ≥98% | A representative biphenyl-tetrazole ARB; used in hypertension-related pharmacology, AT1 receptor experiments, and API/reference and analytical method development. | |
Biphenyl-tetrazole ARB active drug | 137862-53-4 | Valsartan | Moligand™, ≥98% (HPLC) | A common biphenyl-tetrazole ARB; used for AT1 blockade, API/impurity analysis, and formulation studies—classic example of a tetrazole pharmacophore in practice. | |
Biphenyl-tetrazole ARB active drug | 114798-26-4 | Losartan | Moligand™, ≥97% | A representative biphenyl-tetrazole ARB; the tetrazole ring is key for receptor binding; used in pharmacology, SAR, and API analysis studies. | |
Biphenyl-tetrazole ARB active drug (potassium salt) | 124750-99-8 | Losartan Potassium (DuP 753) | ≥99% | A classic biphenyl-tetrazole ARB salt form; used in AT1 pharmacology, reference analyses, and formulation/salt-form research. | |
Tetrazole-containing drug (antibacterial) | 856867-55-5 | Tedizolid Phosphate | ≥98% | A tetrazole-oxazolidinone antibacterial prodrug; used for resistant Gram-positive research, susceptibility testing, mechanism studies, and API/reference analysis. | |
Tetrazole-containing drug (diuretic) | 27589-33-9 | Azosemide | Moligand™, ≥97% | A loop diuretic containing a tetrazole sulfonamide scaffold; used in diuretic pharmacology, transporter/ion cotransport studies, and API/reference and analytical method development. | |
NMTT-side-chain cephalosporin/oxacephem antibacterial | 34444-01-4 | C608445 | Cefamandole | Moligand™ | A representative second-generation cephalosporin with an NMTT side chain; used as a classic β-lactam antibacterial reference, for susceptibility testing, and for NMTT-release/safety studies. |
NMTT-side-chain cephalosporin/oxacephem antibacterial | 56796-20-4 | Cefmetazole | Moligand™, ≥99% | A cephamycin antibacterial with an NMTT side chain; commonly used in anaerobe/Enterobacteriaceae-related studies and as a representative compound for NMTT-related coagulation-risk mechanism research. | |
NMTT-side-chain cephalosporin/oxacephem antibacterial | 62893-19-0 | Cefoperazone | Moligand™, ≥98% | A representative third-generation cephalosporin with an NMTT side chain; used in susceptibility testing, combination therapy, and formulation studies; also a typical molecule in discussions of NMTT-related adverse effects. | |
NMTT-side-chain cephalosporin/oxacephem antibacterial | 69712-56-7 | Cefotetan | Moligand™, ≥96% | A cephamycin antibacterial containing an NMTT (1-methyl-1H-tetrazol-5-ylthio) side chain; used for antibacterial activity/susceptibility studies and often cited in discussions of NMTT-related coagulation risk and disulfiram-like reactions. | |
NMTT-side-chain cephalosporin/oxacephem antibacterial | 64952-97-2 | Latamoxef | Moligand™ | A broad-spectrum oxacephem antibacterial with an NMTT side chain; used for antibacterial efficacy/susceptibility and β-lactam comparisons, and as a representative compound for NMTT-related safety studies. |
Note: The above list represents selected Aladdin products. For more specifications, please refer to the product list at the end of the document or search the Aladdin website by “name/CAS/catalog number.”
For more related articles, please see below:
MTT (tetrazolium salt) colorimetric method
Seed assay by triphenyltetrazolium chloride (TTC) method
Cell proliferation assay: MTT method
